Skip to content
Sunday, October 1, 2023
Latest:
  • An ounce of prevention: does breastfeeding protect against childhood cancer?
  • PARMESAN: An AI-based predictive tool to find new treatments for genetic disorders
  • What is a superfood?
  • Aortic dissection awareness saves lives: Understanding symptoms, causes, treatment options
  • Researchers combat Zika-associated fetal abnormalities using microRNA
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Dipali Pathak
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

estrogen receptor 1

From The Labs

Discovering targetable vulnerabilities in endocrine therapy-resistant breast cancer

May 16, 2023May 16, 2023 endocrine therapy-resistant breast cancer,  ER+ breast cancer,  estrogen receptor 1,  fusion genes,  pralsetinib,  Research,  RET kinase

The findings support evaluating targeting kinase enzymes in a clinical trial to treat this type of breast cancer.

Read More

From the Labs Image of the Month

Oxytocin receptor is dynamically expressed in developing adult-born neurons in the olfactory bulb of the brain. From the Labs: Plasticity of adult-born neurons.

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951